| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.028 | 0.5 |